Since early May 2022 and as of 7 July, cases of monkeypox (MPX) have been reported in non-endemic countries. Twenty-six European Union/European Economic Area (EU/EEA) countries have reported 4 908 cases, representing 65% of all cases reported worldwide in 2022.
Since the epidemic in the Americas peaked in the early spring of 2016, a continuous decline in the number of reported Zika virus disease cases has been observed in the majority of countries throughout the Americas and the Caribbean.
This is an updated assessment of the risks associated with the Zika virus epidemic in affected countries, EU Overseas Countries and Territories, and Outermost Regions and in EU Member States within continental Europe.
In early October, nine cases of autochthonous dengue were confirmed in the EU, three in Spain and six in France, in three separate outbreaks. These are the first autochthonous dengue cases in continental EU/EEA Member States that were reported this year.
Update on the risk of importation and transmission of Ebola virus disease to the EU associated with the outbreak in West Africa currently affecting Guinea, Liberia, Sierra Leone and Nigeria.
Following an increase in the number of cases of Ebola virus disease being recorded in West Africa, ECDC has updated its risk assessment and presents options for prevention and control of the disease for European citizens.
This update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas. It assesses the association between Zika virus infection and congenital central nervous system malformations, including microcephaly, as well as the association between Zika virus infection and Guillain–Barré syndrome.